Pharma channel feed

Rare dis­ease hub at CDER and CBER faces new re­al­i­ty with staff crunch

Last month
FDA+

Drug tool and pack­ag­ing mak­ers to feel brunt of Trump tar­iffs, an­a­lysts say

Last month
Manufacturing

RFK Jr. won’t tes­ti­fy be­fore key Sen­ate com­mit­tee this week on HHS over­haul

Last month
FDA+

Stock mar­ket melts down over Trump’s tar­iffs, and biotech's pain keeps grow­ing

Last month
Financing

Rhythm touts Phase 3 win for rare obe­si­ty drug in peo­ple with brain dam­age

Last month
R&D

GSK’s newest neu­ro pact is with ABL Bio, a Sanofi-part­nered South Ko­re­an biotech

Last month
Deals

Trump ad­min­is­tra­tion leaves obe­si­ty cov­er­age ex­pan­sion out of new Medicare rule

Last month
FDA+

GSK and Pfiz­er re­solve RSV vac­cine patent fight

Last month
Law

No­vavax’s held-up ap­proval pack­age may sig­nal warn­ing for Covid vac­cine mak­ers

Last month
R&D
FDA+

FTC chair­man seeks to re­vive PBM case

Last month
Law

Chi­na's re­tal­ia­to­ry tar­iffs on US could mean more head­winds for drug­mak­ers

Last month
China
Manufacturing

States sue NIH over 'dev­as­tat­ing' grant dis­rup­tions amid health agency shake­up

Last month
Law

Sen­ate con­firms Dr. Oz to lead Medicare agency amid HHS over­haul

Last month
People
FDA+

DOJ at­tor­ney says Boehringer In­gel­heim has 'tremen­dous lever­age' in IRA ne­go­ti­a­tions

Last month

FDA ap­proves Am­gen's Up­liz­na in IgG4-re­lat­ed dis­ease

Last month
FDA+

FDA will con­sol­i­date to five 'shared ser­vices of­fices,' ac­cord­ing to memo to Hill staffers

Last month
FDA+

Aldeyra gets an­oth­er CRL for its dry eye dis­ease drug that Ab­b­Vie has the op­tion to co-de­vel­op

Last month
FDA+

Chaot­ic tar­iff roll­out leaves as many ques­tions as an­swers for drug­mak­ers

Last month
Manufacturing

Trump’s broad tar­iffs ex­empt phar­ma — but for how long?

Last month
FDA+
Manufacturing

FDA cuts stir buy­er’s re­morse for some bio­phar­ma lead­ers, once ex­cit­ed by Trump

Last month
Cell/Gene Tx
FDA+

FTC's fight against PBMs is paused

Last month
Law

Eli Lil­ly adds obe­si­ty start­up known­well to its di­rect-to-con­sumer ser­vice

Last month
Startups
Health Tech

Q&A: John Crow­ley warns biotech is 'dan­ger­ous­ly close' to break­ing, as tar­iff threat, mar­kets bat­ter in­dus­try

Last month
People
FDA+

Judge or­ders HHS, oth­er agen­cies to 'un­do' pro­ba­tion­ary work­er fir­ings

Last month
FDA+
First page Previous page 6789101112 Next page Last page
A service from the Financial Times